Skip to main content Skip to navigation

Treat-Nmd Alliance LTD

Treat NMD exists to accelerate treatments to patients with neuromuscular disease, by engaging withpatient advocacy groups, researchers, clinicians, industry and regulators to advance treatments and sharebest practice.

Email Charity

Activities & Mission

Treat NMD exists to accelerate treatments to patients with neuromuscular disease, by engaging withpatient advocacy groups, researchers, clinicians, industry and regulators to advance treatments and sharebest practice.

Areas of Operation

Where this charity is registered to operate, as self-declared to the Charity Commission. These are regulatory classifications, not a list of active programmes, and don't necessarily indicate fundraising activity in each location.

Financial Information

Latest Income
£2,479,051
Latest Expenditure
£2,518,415

Financial Efficiency

Program Ratio 10.2%
% of income going directly to charitable activities
Overall Efficiency 10.0%
% of expenditure going to programs (vs overhead)
Administrative Ratio 90.0%
Overhead (fundraising + governance) as % of total expenditure

Latest Financial Breakdown

Income Sources

Donations & Legacies £0
Charitable Activities £478,182
Other Trading £1,999,150
Investments £1,719
Other Income £0

Expenditure Categories

Charitable Expenditure £253,077
Raising Funds £2,265,338
Governance £0
Grants to Institutions £14,925
Other Expenditure £0

Financial Trend

Annual Returns

As filed with the Charity Commission for England and Wales. Most recent filing covers the financial year ending 2024.

Financial YearIncomeExpenditureCharitable SpendingNet AssetsReservesStaff
2024
£2,479,051
£2,518,415£253,077£837,146£837,14619 / 0
2023
£2,247,123
£1,892,921£177,005£876,510£876,51015 / 0

Staff column shows: Employees / Volunteers

Frequently asked questions about Treat-Nmd Alliance LTD

What does Treat-Nmd Alliance LTD do?

Treat NMD exists to accelerate treatments to patients with neuromuscular disease, by engaging withpatient advocacy groups, researchers, clinicians, industry and regulators to advance treatments and sharebest practice.

How much income did Treat-Nmd Alliance LTD report in 2024?

Treat-Nmd Alliance LTD reported total income of £2.48m and reported expenditure of £2.52m for the financial year ending 2024, based on the most recent annual return filed with the Charity Commission.

When was Treat-Nmd Alliance LTD registered as a charity?

Treat-Nmd Alliance LTD was registered with the Charity Commission for England and Wales on 20 October 2022 as charity number 1200765. It has been registered for 4 years.

Who runs Treat-Nmd Alliance LTD?

Treat-Nmd Alliance LTD is governed by a board of 4 trustees. The chair of trustees is Dr Kathryn Wagner. Trustees are legally responsible for the charity's governance and are listed in full on its profile.

Where does Treat-Nmd Alliance LTD operate?

Treat-Nmd Alliance LTD operates in England And Wales, as recorded in its Charity Commission filing.

Is Treat-Nmd Alliance LTD a registered charity?

Yes — Treat-Nmd Alliance LTD is a registered charity in England and Wales, charity number 1200765.

Details

Address
4th Floor
The Catalyst
NEWCASTLE HELIX
NEWCASTLE UPON TYNE
NE4 5TG
Registration Date
20 October 2022
Status
Registered

Registry Information

Organisation Number
5204411
Charity Number
1200765

Is this your charity?

Add your logo, photos and tell the story behind the numbers in your own words. Free for our first 50 launch partners.

Claim this listing Learn more about premium profiles

Trustees

Dr Kathryn Wagner Chair
Prof and Dean Kanneboyina Nagaraju
Robert von Rosen
Volker Wilhelm Straub

Data & trust

Register data refreshed
30 July 2026
Report a data issue